Issue 3/2008
Content (15 Articles)
Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence
Stephanie A. Navarro Silvera, Thomas E. Rohan
Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC)
Ander Urruticoechea, Monica Arnedos, Geraldine Walsh, Mitch Dowsett, Ian E. Smith
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases
Dmitry A. Turbin, Samuel Leung, Maggie C. U. Cheang, Hagen A. Kennecke, Kelli D. Montgomery, Steven McKinney, Diana O. Treaba, Niki Boyd, Lynn C. Goldstein, Sunil Badve, Allen M. Gown, Matt van de Rijn, Torsten O. Nielsen, C. Blake Gilks, David G. Huntsman
The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome
Andrew R. Green, Claire Burney, Christopher J. Granger, E. Claire Paish, Somaia El-Sheikh, Emad A. Rakha, Desmond G. Powe, R. Douglas Macmillan, Ian O. Ellis, Eleni Stylianou
Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria
Lorenza Putignani, Salvatore Raffa, Roberta Pescosolido, Laura Aimati, Fabrizio Signore, Maria Rosaria Torrisi, Paola Grammatico
Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers
Ankit Bharat, Nicholas Benshoff, Timothy P. Fleming, Jill R. Dietz, William E. Gillanders, T. Mohanakumar
Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer
Yutaka Yamamoto, Mutsuko Ibusuki, Yasuhiro Okumura, Teru Kawasoe, Kazuharu Kai, Kenichi Iyama, Hirotaka Iwase
Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables
Woo Chul Noh, Yang Hee Kim, Min Suk Kim, Jae Soo Koh, Hyun-Ah Kim, Nan Mo Moon, Nam-Sun Paik
Favourable long-term results after surgical removal of lung metastases of breast cancer
Masataka Yoshimoto, Keiichiro Tada, Seiichiro Nishimura, Masujiro Makita, Takuji Iwase, Fujio Kasumi, Sakae Okumura, Yukitoshi Sato, Ken Nakagawa
Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells
Jennifer L. Gilmore, Jeffrey A. Scott, Zhor Bouizar, Alex Robling, Sarah E. Pitfield, David J. Riese II, John Foley
Effects of exon-deleted estrogen receptor β transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines
Oliver Treeck, Ingolf Juhasz-Boess, Claus Lattrich, Felicitas Horn, Regina Goerse, Olaf Ortmann
Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue
Vanesa Martinez, Susan Kennedy, Padraig Doolan, Patrick Gammell, Helena Joyce, Elaine Kenny, Jai Prakash Mehta, Eoin Ryan, Robert O’Connor, John Crown, Martin Clynes, Lorraine O’Driscoll
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival
Masakazu Toi, Seigo Nakamura, Katsumasa Kuroi, Hiroji Iwata, Shinji Ohno, Norikazu Masuda, Mikihiro Kusama, Kosuke Yamazaki, Kazuhumi Hisamatsu, Yasuyuki Sato, Masahiro Kashiwaba, Hiroshi Kaise, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Yuichi Takatsuka
Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors
Hakan Harputluoglu, Omer Dizdar, Fatih Karaahmet, Kadri Altundag
Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population
Patricio González-Hormazábal, Víctor G. Castro, Rafael Blanco, Fernando Gómez, Octavio Peralta, Enrique Waugh, Teresa Bravo, Jose M. Reyes, Lilian Jara